By G HossainPosted on July 22, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Top-selling cell therapies from BMS, J&J and Gilead depend on a BioLife product, positioning Repligen to use the takeover to increase its exposure to the modality. Repligen strikes $1.5B BioLife buyout to bag cell therapy product pharmas rely on Post navigation From Big Pharma to specialty: why moving closer to the patient changes everythingSummit and Akeso sharpen case for ivonescimab with new Western data
